Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study in Healthy Adult Participants Pre-treated With INNA-051 and Challenged With Influenza Virus

NCT05255822 is registered in ClinicalTrials.gov with ENA Respiratory Pty Ltd as lead sponsor.

NCT NCT05255822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05255822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study in Healthy Adult Participants Pre-treated With INNA-051 and Challenged With Influenza Virus
Lead sponsor
ENA Respiratory Pty Ltd
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2022
Completion date
August 23, 2022
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza prophylaxis